Cellular and Molecular Gastroenterology and Hepatology

News

09 Sep 2022
Osaka Metropolitan University scientists developed a new method to isolate hepatic stellate cells (HSCs), which play a significant role in liver cancer progression. With enzymatic cold perfusion and utilization of an antibody against CD49a, a reliable HSC surface marker, the new method allows HSC isolation with high yield and purity from livers with various conditions, be they normal or fatty tumor-prone, from both mice and humans. The findings are expected to contribute to the development of efficient tools for characterizing NASH- or fatty liver-based liver cancer.